Assessment of perampanel (E2007) on synaptic dopamine in mild-moderate PD [Parkinson's disease] patients: A pilot study with [123I]-IBZM [iodobenzamide] SPECT [single photon emission computed tomography].
Phase of Trial: Phase II
Latest Information Update: 21 Dec 2012
At a glance
- Drugs Perampanel (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- Sponsors Eisai Medical Research
- 08 May 2008 Status change from recruiting to discontinued, due to a lack of efficacy, according to clinicaltrials.gov.
- 11 Dec 2007 New trial record.